FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Profarma Distributors tabcin ACTIVE M Recall

tabcin ACTIVE M

Profarma Distributors LLC · Columbus, OH

Risk level
Class II
Reported by FDA
Jun 29, 2016
Recall ID
D-1039-2016
Check your lot numberHow we source this data

Summary

Profarma Distributors recalled tabcin ACTIVE M starting May 11, 2016. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1039-2016 on Jun 29, 2016. Reason: CGMP Deviations. Status: Terminated.

Why it was recalled

CGMP Deviations

Product description

tabcin ACTIVE M.R. Capsules, 12-count box , UPC 7501008485057

Lot numbers, UPCs & expiration codes

Lot # 224TS; Exp. 02/17

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1039-2016
Classification
Class II
Status
Terminated
Recall initiated
May 11, 2016
FDA report date
Jun 29, 2016
Quantity
42 boxes (504 capsules)
Recall type
Voluntary: Firm initiated
Recalling firm
Profarma Distributors LLC

Original FDA data

Every field from FDA enforcement report D-1039-2016, exactly as published.

Show all FDA fields
City
Columbus
State
OH
Status
Terminated
Country
United States
Event ID
74135
Address
4751 Poth Rd
Code information
Lot # 224TS; Exp. 02/17
Postal code
43213-1331
Report date
Jun 29, 2016
Product type
Drugs
Recall number
D-1039-2016
Classification
Class II
Recalling firm
Profarma Distributors LLC
Product quantity
42 boxes (504 capsules)
Termination date
Jan 24, 2017
Reason for recall
CGMP Deviations
Voluntary / mandated
Voluntary: Firm initiated
Product description
tabcin ACTIVE M.R. Capsules, 12-count box , UPC 7501008485057
Distribution pattern
Nationwide
Recall initiation date
May 11, 2016
Initial firm notification
Letter
Center classification date
Jun 17, 2016

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1039-2016, published Jun 29, 2016. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls